1.
|
Phase: Phase III, Phase II Type: Behavioral study, Prevention Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: NURA-001-09S, NCT00960375
|
|
2.
|
Phase: Phase III, Phase II Type: Behavioral study, Prevention Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: NIDA-16427-5, R01-16427-5, DPMC, NCT00132821
|
|
3.
|
Phase: Phase III Type: Educational/Counseling/Training, Prevention Status: Active Age: 25 to 65 Sponsor: NCI, Other Protocol IDs: 2008-0850, R01DA024709-01A1, NCT00943618
|
|
4.
|
Phase: Phase II, Phase I Type: Behavioral study, Prevention Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 11862, NCT01106456
|
|
5.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2009-0517, NCT01219673
|
|
6.
|
Phase: Phase II Type: Behavioral study, Prevention Status: Active Age: 21 and over Sponsor: Other Protocol IDs: HIC0702002391, R01AA015596-01, NCT00580645
|
|
7.
|
Phase: No phase specified Type: Behavioral study, Prevention Status: Approved-not yet active Age: 13 to 20 Sponsor: Other Protocol IDs: GehaMHC, No grants so far, NCT00819078
|
|
8.
|
Phase: No phase specified Type: Behavioral study, Prevention Status: Active Age: 19 to 80 Sponsor: NCI, Other Protocol IDs: R01CA141663, R01CA141663-01, NCT01257490
|